Trandolapril Impurity D is a specified impurity associated with the active pharmaceutical ingredient (API) Trandolapril. It is a known process-related degradation product or synthetic intermediate formed during the manufacturing of Trandolapril, an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. As a defined impurity, Trandolapril Impurity D is critical for pharmaceutical quality control. It is used as a reference standard in analytical chemistry to monitor and control the impurity profile of Trandolapril drug substances and finished products. Its primary application is in the development and validation of stability-indicating analytical methods, such as high-performance liquid chromatography (HPLC), to ensure the drug's safety, efficacy, and compliance with regulatory standards set by pharmacopoeias like USP, EP, and ICH guidelines.